Allogene Therapeutics
Babu Kish has extensive experience in information technology, currently serving as Senior Manager of IT Infrastructure and Cloud at Allogene Therapeutics since January 2020. In addition to this role, Babu Kish has been with Rambus since January 2005, where the positions held include Senior Information Technology Manager and overseeing the Rambus India IT system. With a robust background in managing IT infrastructure and systems, Babu Kish demonstrates strong leadership and technical expertise in the field.
Allogene Therapeutics
1 followers
Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. The goal of our allogeneic cell therapy platform is simple: take the same biological processes that allow the first generation autologous CAR T therapies to deliver breakthrough clinical benefits but eliminate the need to create a personalized therapy for each patient. Instead, we start with T cells from healthy donors, which is intended to allow for creation of inventory for “off-the-shelf” use in patients faster, more reliably, and at greater scale.